Pure Global

PROG Rapid Quantitative Test - India CDSCO Medical Device Registration

PROG Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_de2caec82c084c773e5b577be9ab7d55_8dbbfff199e1f50d1b4d1fe0a183cf5b. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
PROG Rapid Quantitative Test
UID: IMP/IVD/2022/000074_de2caec82c084c773e5b577be9ab7d55_8dbbfff199e1f50d1b4d1fe0a183cf5b

Brand Name

Glycated Hemoglobin

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Aehealth Progesterone Rapid Quantitative Test is a fluorescence immunoassay used along with Aehealth FIA System for quantitative determination of progesterone concentration in human whole blood, serum or plasma specimen. The test is used as an aid to track ovulation, monitor the effect of progesterone therapies and in early pregnancy to help diagnose an ectopic or failing pregnancy

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing